ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $541K of Zentalis Pharmaceuticals, Inc.
Sold$540,551
$54.06Price
10,000Shares
−2%Stake
What ZNTL did after the filing
- The stock from Thu, Jun 3 open, $52.93
- −10.5%
- S&P 500, same days
- +3.6%
Measured over 30 trading days, to the Jul 16 close.
Traded Tue, Jun 1. Filed Wed, Jun 2, 4:27 PM ET, after the close. Returns use the Jun 3 open and the Jul 16 close. Not investment advice.